Nabriva Therapeutics Plc (NBRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBRV | ESLA | GNTA | ||
| Company | Nabriva Therapeutics Plc | Estrella Immunopharma Inc | Genenta Science S.P.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.4500 | 1.1100 | 1.9000 | ||
| High | 1.9000 | 1.1100 | 1.9000 | ||
| Low | 1.3500 | 1.0000 | 1.7600 | ||
| Latest | 1.4200 | 1.0300 | 1.8000 | ||
| Change | unch | -0.0300 | -0.0700 | ||
| % Change | unch | -2.83% | -3.74% | ||
| Volume | 717,200 | 40,300 | 249,500 | ||
| 20-Day Average Volume | 46,640 | 38,400 | 4,305,190 | ||
| Previous Close | 1.4200 | 1.0600 | 1.8700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5446 | 1.1130 | 1.3493 | ||
| 20-Day Raw Stochastic | 12.73% | 12.50% | 61.58% | ||
| 20-Day Relative Strength | 42.54 | 39.09 | 64.42 | ||
| Weighted Alpha | -50.30 | -55.43 | -60.90 | ||
| Today's Opinion | 100% Sell | 88% Sell | 40% Buy | ||
| Previous Opinion | 100% Sell | 88% Sell | 40% Buy | ||
| Last Month's Opinion | 88% Sell | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.35% since 07/24/23 | -8.85% since 06/08/26 | unch since 06/08/26 | ||
| Low | 1.3500 on 07/31/23 | 1.0000 on 06/15/26 | 1.3500 on 06/10/26 | ||
| High | 1.9000 on 07/31/23 | 1.2097 on 06/09/26 | 1.9300 on 06/11/26 | ||
| 1-Month | |||||
| %Chg | -5.96% since 06/30/23 | -7.21% since 05/15/26 | +186.62% since 05/15/26 | ||
| Low | 1.3500 on 07/31/23 | 1.0000 on 06/15/26 | 0.5500 on 05/26/26 | ||
| High | 1.9000 on 07/31/23 | 1.2400 on 05/28/26 | 2.5800 on 06/02/26 | ||
| 3-Month | |||||
| %Chg | -11.26% since 04/28/23 | -18.25% since 03/13/26 | +104.55% since 03/13/26 | ||
| Low | 1.3500 on 07/31/23 | 0.9700 on 03/23/26 | 0.5500 on 05/26/26 | ||
| High | 2.2400 on 05/19/23 | 2.1000 on 04/08/26 | 2.5800 on 06/02/26 | ||
| 6-Month | |||||
| %Chg | -8.39% since 01/30/23 | -43.09% since 12/15/25 | +26.76% since 12/15/25 | ||
| Low | 1.2600 on 03/27/23 | 0.9002 on 01/22/26 | 0.5500 on 05/26/26 | ||
| High | 2.2400 on 05/19/23 | 2.1000 on 04/08/26 | 2.5800 on 06/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 45,461 | 45,616 | 44,115 | ||
| Shares Outstanding, K | 32,015 | 43,034 | 23,591 | ||
| Annual Sales | 36,940,000 | 0 | 0 | ||
| Annual Net Income | -57,190,000 | -13,060,000 | -7,390,000 | ||
| Last Quarter Sales | 7,590,000 | 0 | N/A | ||
| Last Quarter Net Income | -8,700,000 | -2,290,000 | N/A | ||
| 60-Month Beta | 1.53 | 0.85 | 0.90 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.72 on 05/22/23 | -0.05 on 05/15/26 | N/A | ||
| Earnings Date | 08/02/23 | 05/13/26 | 04/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||